Tocilizumab and Regression of Rheumatoid Nodules in Patients with Rheumatoid Arthritis: 2 Case ReportsHaider M Al Attia*
Internal Medicine and Rheumatology, Al Mazroui Medical Centre, Abu Dhabi, UAE
- *Corresponding Author:
- Haider M Al Attia
Consultant in Internal Medicine and Rheumatology
Al Mazroui Medical Centre, Abu Dhabi, UAE
Email: [email protected]
Received Date: February 7, 2014; Accepted Date: October 1, 2014; Published Date: October 15, 2014
Citation: Attia HMA (2014) Tocilizumab and Regression of Rheumatoid Nodules in Patients with Rheumatoid Arthritis: 2 Case Report. Rheumatology (Sunnyvale) S5:009. doi: 10.4172/2161-1149.S5-009
Copyright: © 2014 Attia HMA. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
We report two cases of females with seropositive and deforming nodular rheumatoid arthritis. They responded well to TCZ therapy after failing to other anti RA therapeutics (DMRDs and biologics). The nodules disappeared following TZC in both patients but they reappeared in one patient after 5 months of cessation of the TCZ.